DHR (DHR) Stock Analysis

DHR (DHR) is a publicly traded company in the HEALTHCARE sector. It trades at $179.87, carries a market capitalization of $127.31B, a price-to-earnings ratio of 34.86. This page summarizes the public market data, fundamentals, and frequently asked questions for DHR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NYSE

Key Metrics

• Price: $179.87
• Market Cap: $127.31B
• P/E Ratio: 34.86
• EPS: $5.16
• 52-Week High: $242.28
• 52-Week Low: $160.93

Market Sentiment

DHR currently has a Bullish sentiment score of 0.19.

About DHR

Danaher Corporation is a prominent American diversified conglomerate based in Washington, D.C., recognized for its cutting-edge innovations across multiple sectors, including Life Sciences, Diagnostics, and Environmental & Applied Solutions. The company employs advanced technologies to advance healthcare and improve efficiencies in industrial processes worldwide, demonstrating a strong commitment to enhancing patient outcomes and operational performance. With a diverse portfolio of scientific...

GNG Research Analysis

GNG Research scores DHR (DHR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DHR.

Frequently Asked Questions

Does DHR pay dividends?

DHR (DHR) does not currently pay a regular dividend.

What is DHR's P/E ratio?

DHR has a price-to-earnings (P/E) ratio of 34.86.

What is DHR's market cap?

DHR (DHR) has a market capitalization of $127.31B with a current stock price of $179.87.